Maria Jose G. Teruel, Ph. D. , Luis F. Carbonell, Ph. D

Slides:

Advertisements

Similar presentations

Early-stage endometriosis: adhesion and growth of human menstrual endometrium in nude mice Michelle Nisolle, M.D., Ph.D., Françoise Casanas-Roux, B.S.,

Advertisements

Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles Ryan G. Steward,

Low-dose aspirin therapy to prevent ovarian hyperstimulation syndrome

Elevated serum progesterone-to-estradiol ratio during gonadotropin stimulation for intrauterine insemination or in vitro fertilization is not associated.

Is the type of gonadotropin-releasing hormone suppression protocol for ovarian hyperstimulation associated with ectopic pregnancy in fresh autologous.

Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment Javier Domingo, M.D., Vicente.

Effects of age on the risk of dying from pulmonary embolism or bleeding during treatment of deep vein thrombosis Juan Francisco Sanchez Muñoz-Torrero,

The antiandrogenic effect of flutamide improves uterine perfusion in women with polycystic ovary syndrome Silvia Ajossa, M.D., Stefano Guerriero, M.D.,

Elevated serum progesterone-to-estradiol ratio during gonadotropin stimulation for intrauterine insemination or in vitro fertilization is not associated.

Local injury to the endometrium in controlled ovarian hyperstimulation cycles improves implantation rates Liang Zhou, M.D., Rong Li, M.D., Ph.D., Rong.

No difference in cycle pregnancy rate and in cumulative live-birth rate between women with surgically treated minimal to mild endometriosis and women.

Postparacentesis bilateral massive vulvar edema in a patient with severe ovarian hyperstimulation syndrome Dimitrios Vavilis, M.D., Stergios Tzitzimikas,

Value of the serum estradiol level for preventing ovarian hyperstimulation syndrome: a retrospective case control study Arianna D'Angelo, M.D., Rachel.

Kalliopi Kotsa, M. D. , Ph. D. , Maria P. Yavropoulou, M. D

Marcos Meseguer, Ph. D. , Rebeca Santiso, Ph. D. , Nicolás Garrido, Ph

Chromosomal translocation 3;22 in an infertile man

Effect of the initiation of progesterone supplementation in in vitro fertilization–embryo transfer outcomes: a prospective randomized controlled trial

Day 4 Estradiol Levels Predict Pregnancy Success in Women Undergoing Controlled Ovarian Hyperstimulation for IVF John Y Phelps, M.D., Adam S Levine,

Konstantinos Pantos, M. D. , Evangelos Makrakis, M. D

Angela C Meyer, M. D. , John C Papadimitriou, M. D. , Ph. D

Ovarian hyperstimulation syndrome as a rare cause of acute bilateral limb and renal ischemia Anita Quintas, MD, Maria Emilia Ferreira, MD, Frederico.

The pathogenesis of ovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin-1β, interleukin-6, and vascular endothelial.

Predicted value of renin activity in a woman who had severe ovarian hyperstimulation syndrome with internal jugular vein thrombosis Fung-Wei Chang, M.D.,

A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data

Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian.

Vivian Barak, Ph. D. , Uriel Elchalal, M. D. , Michal Edelstein, M. D

Patients with severe ovarian hyperstimulation syndrome can be managed safely with aggressive outpatient transvaginal paracentesis Laura P. Smith, M.D.,

Endometrial wavelike activity, endometrial thickness, and ultrasound texture in controlled ovarian hyperstimulation cycles Marga M IJland, M.D., Johannes.

From partner's desk to iPad

Mohamed Fawzy, M. D. , Mohamed Y. AbdelRahman, M. D. , Mohamed H

Pretreatment with estrogen does not affect IVF-ICSI cycle outcome compared with no pretreatment in GnRH antagonist protocol: a prospective randomized.

Reduction of ovarian torsion 1 week after embryo transfer in a patient with bilateral hyperstimulated ovaries Anil B Pinto, M.D., Valerie S Ratts, M.D.,

Uterine artery embolization for fibroids does not have adverse effects on ovarian reserve in regularly cycling women younger than 40 years Giovanna Tropeano,

Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D.

Thomas M. D’Hooghe, M. D. , Ph. D. , Bénédicte Denys, M. D

Lisa C. Grossman, B. A. , Konstantinos G. Michalakis, M. D

Noha H Farag, M. D. , Scott C Matthews, M. D. , Eva Brzezinski, M. S

Endocrine gland–derived vascular endothelial growth factor concentrations in follicular fluid and serum may predict ovarian hyperstimulation syndrome.

Storage of human oocytes in the vapor phase of nitrogen

Ovarian endometrioma vascularization in women with pelvic pain

Concentration of vascular endothelial growth factor released by cultured human luteinized granulosa cells is higher in women with polycystic ovaries than.

Treatment of ovarian hyperstimulation syndrome using a dopamine agonist and gonadotropin releasing hormone antagonist: a case series Nanette L. Rollene,

Fertility preservation in girls with Turner syndrome: limitations, current success and future prospects Kutluk Oktay, M.D., Ph.D., Giuliano Bedoschi,

Pyridostigmine cotreatment for controlled ovarian hyperstimulation in low responders undergoing in vitro fertilization–embryo transfer Chung-Hoon Kim,

Regulation of assisted reproductive technologies in the United States

Cameron Gilbert, M. Sc. , Maria Valois, M. D. , FRCPC, Ph. D

Effect of endometriosis on in vitro fertilization

Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.

A case of ovarian hyperstimulation syndrome associated with the methylenetetrahydrofolate reductase mutation gene Filippo Ferrara, M.D., Francesco Meli,

Are endometrial parameters by three-dimensional ultrasound and power Doppler angiography related to in vitro fertilization/embryo transfer outcome? Luis.

Cabergoline and Ganirelix Therapy for Early Moderate to Severe Ovarian Hyperstimulation Syndrome (OHSS) Results in Faster Recovery than in Early Untreated.

Stephanie A. Beall, M.D., Ph.D., Alan DeCherney, M.D.

Effect of angiotensin-converting enzyme inhibitor on renal function in ovarian hyperstimulation syndrome in the rabbit Maria Jose G Teruel, Ph.D., Luis.

Anuja Dokras, M. D. , Ph. D. , Antonia Habana, M. D. , Juan Giraldo, M

Sedigheh Borna, M.D., Azita Nasery, M.D. Fertility and Sterility

MicroRNA: key gene expression regulators

Impact of luteinizing hormone administration on gonadotropin-releasing hormone antagonist cycles: an age-adjusted analysis Ernesto Bosch, M.D., Elena.

Chronology of hemodynamic changes in asymptomatic in vitro fertilization patients and relationship with ovarian steroids and cytokines Dolors Manau,

Cost-effectiveness comparison between pituitary down-regulation with a gonadotropin- releasing hormone agonist short regimen on alternate days and an antagonist.

Percutaneous oocyte retrieval from an inguinal ovary

Soluble ICAM-1 and E-selectin levels correlate with clinical and biological aspects of severe ovarian hyperstimulation syndome Yoram Abramov, M.D., Joseph.

Altered osmotic thresholds for arginine vasopressin secretion and thirst during superovulation and in the ovarian hyperstimulation syndrome (OHSS): relevance.

Diane De Neubourg, M. D. , Kathelijne Mangelschots, B. Sc

Effectiveness of human menopausal gonadotropin versus recombinant follicle- stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive.

Bárbara Oriol, M. D. , Ana Barrio, M. D. , Alberto Pacheco, Ph. D

William R. Boone, Ph. D. , Jeffrey M. Jones, Ph. D. , Sander S

Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles

Low-dose aspirin therapy to prevent ovarian hyperstimulation syndrome

Ongoing pregnancy rates in intrauterine insemination are affected by late follicular- phase progesterone levels Antonio Requena, M.D., María Cruz, Ph.D.,

Thyroid function after controlled ovarian hyperstimulation in women with and without the hyperstimulation syndrome Kris Poppe, M.D., Ph.D., David Unuane,

Presentation transcript:

Hemodynamic state and the role of angiotensin II in ovarian hyperstimulation syndrome in the rabbit Maria Jose G. Teruel, Ph.D., Luis F. Carbonell, Ph.D., Maria Carmen Llanos, M.D., Juan J. Parrilla, Ph.D., Lorenzo Abad, Ph.D., Isabel Hernandez, M.D., Ph.D. Fertility and Sterility Volume 77, Issue 6, Pages 1256-1260 (June 2002) DOI: 10.1016/S0015-0282(02)03085-6

FIGURE 1 Baseline hemodynamic variables in control rabbits, rabbits with the ovarian hyperstimulation syndrome (OHSS), and rabbits with OHSS that received captopril (OHSS+Cap). Values are means (±SE). MAP = mean arterial pressure; TPR = total peripheral resistance. Teruel. OHSS and hemodynamic state. Fertil Steril 2002. Fertility and Sterility 2002 77, 1256-1260DOI: (10.1016/S0015-0282(02)03085-6)